Author(s): Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG
The object of the experiment was to verify whether cannabidiol (CBD) reduces the anxiety provoked by delta 9-THC in normal volunteers, and whether this effect occurs by a general block of the action of delta 9-THC or by a specific anxiolytic effect. Appropriate measurements and scales were utilized and the eight volunteers received, the following treatments in a double-blind procedure: 0.5 mg/kg delta 9-THC, 1 mg/kg CBD, a mixture containing 0.5 mg/kg delta 9-THC and 1 mg/kg CBD and placebo and diazepam (10 mg) as controls. Each volunteer received the treatments in a different sequence. It was verified that CBD blocks the anxiety provoked by delta 9-THC, however this effect also extended to marihuana-like effects and to other subjective alterations induced by delta 9-THC. This antagonism does not appear to be caused by a general block of delta 9-THC effects, since no change was detected in the pulse-rate measurements. Several further effects were observed typical of CBD and of an opposite nature to those of delta 9-THC. These results suggest that the effects of CBD, as opposed to those of delta 9-THC, might be involved in the antagonism of effects between the two cannabinoids.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/6285406
Author(s): Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO
Author(s): Costa B
Author(s): Russo E, Guy GW
Author(s): Mikes F, Waser PG
Author(s): Burgdorf JR, Kilmer B, Pacula RL
Author(s): Van der Kooy F, Pomahacova B, Verpoorte R
Author(s): Sullivan N, Elzinga S, Raber JC
Author(s): Hazekamp A, Peltenburg A, Verpoorte R, Giroud C
Author(s): Moir D, Rickert WS, Levasseur G, Larose Y, Maertens R, et al.
Author(s): Adams R, Cain CK, McPhee WD, Wearn RB